SLC18A3: Vesicular Acetylcholine Transporter

Key regulator of cholinergic neurotransmission and neuromuscular junction function

Gene Information Card

Symbol SLC18A3
Full Name Solute carrier family 18 member A3
Gene Type Protein coding
Chromosomal Location 10q11.23
NCBI Gene ID 6572 ncbi.nlm.nih.gov/gene/6572
Ensembl ID ENSG00000187714
UniProt ID Q16572
OMIM ID 600336
HGNC ID 10936
Aliases VAChT, VACHT, CGI-62, dJ55C23.6

Description

SLC18A3 encodes the vesicular acetylcholine transporter (VAChT), a transmembrane protein that transports acetylcholine from the cytoplasm into synaptic vesicles in cholinergic neurons. This transport is essential for quantal release of acetylcholine at the neuromuscular junction and in the autonomic nervous system. The gene is located within the first intron of the choline acetyltransferase (CHAT) gene, allowing coordinated expression. Mutations in SLC18A3 cause presynaptic congenital myasthenic syndrome (CMS) due to impaired acetylcholine loading.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Presynaptic congenital myasthenic syndrome (CMS) Loss-of-function mutations reduce acetylcholine transport into synaptic vesicles, leading to decreased quantal release and neuromuscular transmission failure Multiple families with biallelic missense/nonsense variants; functional studies show reduced acetylcholine uptake
Myasthenia gravis (autoimmune) Autoantibodies against VAChT may contribute to cholinergic dysfunction in some patients Case reports; limited evidence

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.3 Medium
Spinal cord 8.7 Medium
Skeletal muscle 0.2 Not detected
Heart 0.1 Not detected
Liver 0.0 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 45.2 High expression; cholinergic phenotype
SK-N-SH (neuroblastoma) 22.1 Moderate expression
HepG2 (hepatocellular carcinoma) 0.0 No expression
HeLa (cervical carcinoma) 0.0 No expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.4A>G (p.Met1?) Start loss Rare Loss of translation initiation; severe CMS
c.107G>A (p.Arg36His) Missense Rare Reduced acetylcholine transport activity
c.1165C>T (p.Arg389*) Nonsense Rare Truncated protein; loss of function
c.1262T>C (p.Leu421Pro) Missense Rare Impaired vesicular targeting and transport
Mutation functional classification

Loss of Function (LOF)

Most reported mutations are loss-of-function, reducing acetylcholine uptake into synaptic vesicles, leading to presynaptic CMS.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported; disease is autosomal recessive.

Pathways

Acetylcholine synthesis and transport (Reactome: R-HSA-264642)
Neurotransmitter release cycle (Reactome: R-HSA-112310)
Cholinergic synapse (KEGG: hsa04725)

Protein Summary

The vesicular acetylcholine transporter (VAChT) is a 530-amino acid integral membrane protein with 12 transmembrane domains. It uses a proton gradient generated by vacuolar ATPase to drive acetylcholine uptake into synaptic vesicles. VAChT is expressed exclusively in cholinergic neurons and is essential for efficient neuromuscular transmission. Its expression is tightly co-regulated with choline acetyltransferase (CHAT).

Related Products

Product name Cat.No. Species Gene ID
SLC18A3 Knockout HEK293 Cell Line EDJ-KQ5794 Human 6572 Details Get a Quote
SLC18A3 Knockout HeLa Cell Line EDJ-KQ54516 Human 6572 Details Get a Quote
SLC18A3 Knockout A-549 Cell Line EDJ-KQ63001 Human 6572 Details Get a Quote
SLC18A3 Knockout HCT 116 Cell Line EDJ-KQ71471 Human 6572 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: